British neonatal consultant to present at Arab Health 2017
NEWS - 2ND DECEMBER 2016
A Harley Street Medical Area consultant has been invited to speak at the forthcoming Arab Health Congress 2017
Behind its Georgian facade lays the latest in cutting edge medical technology and it is proud to offer unique and complex treatments by renowned doctors such as Dr Kapellou.
The Arab Health Congress delivers the highest quality of Continuing Medical Education (CME) to medical professionals in the region. More than 13,700 delegates from around the world attend the event, with the conference programme attracting a global appeal with international speakers covering a broad spectrum of medical specialities and disciplines.
Dr Kapellou will present on Neonatal hyperbilirubinemia at Session 5 as part of the Paediatrics Conference on 30th January 2017 at 16:50pm.
Speaking about jaundice, Dr Kapellou said: “Although neonatal jaundice is generally harmless, high concentrations of unconjugated bilirubin may occasionally cause permanent brain damage. This is a rare condition - about seven new cases each year in the United Kingdom, but the consequences of this include choreoathetoid cerebral palsy or deafness.”
“Jaundice can also be a sign of serious liver disease, the prognosis for which is better if it is treated before the age of 6 weeks. Early recognition of jaundice is therefore vital for treatment of any underlying condition and for the appropriate use of phototherapy, which can safely control bilirubin concentrations in most cases.”
HCA Healthcare UK is just one of the world-leading clinics located in the Harley Street Medical Area. Famed for its medical excellence in treating complex and life threatening conditions for over 200 years, it continues to attract world-leading clinics.
Dr Olga Kapellou, Consultant Paediatrician & Neonatologist, from HCA Healthcare UK, will be speaking about her experiences in the UK and the recommendations from the National Institute for Health and Clinical Excellence (NICE).
Dr Kapellou, who specialises in preterm and term infant developmental follow up, will also discuss how to diagnose and treat jaundice in newborn babies up to 28-days old.
Neonatal hyperbilirubinemia or jaundice is one of the most common conditions needing medical attention in newborn babies.
About 60% of term and 80% of preterm babies develop jaundice in the first week of life, and about 10% of breast-fed babies are still jaundiced at age 1 month.